Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial
Titel:
Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial
Auteur:
Tournigand, Christophe Chibaudel, Benoist Samson, Benoit Scheithauer, Werner Vernerey, Dewi Mésange, Paul Lledo, Gérard Viret, Frédéric Ramée, Jean-François Tubiana-Mathieu, Nicole Dauba, Jérôme Dupuis, Olivier Rinaldi, Yves Mabro, May Aucoin, Nathalie Latreille, Jean Bonnetain, Franck Louvet, Christophe Larsen, Annette K André, Thierry de Gramont, Aimery